$1.00
1.96% today
Nasdaq, Apr 04, 09:16 pm CET
ISIN
US7743741024
Symbol
RMTI

Rockwell Medical, Inc. Stock price

$1.02
-0.57 35.85% 1M
-2.54 71.35% 6M
-1.02 50.00% YTD
-0.61 37.42% 1Y
-3.63 78.07% 3Y
-18.78 94.85% 5Y
-114.37 99.12% 10Y
Nasdaq, Closing price Thu, Apr 03 2025
-0.10 8.93%
ISIN
US7743741024
Symbol
RMTI
Sector

Key metrics

Market capitalization $34.74m
Enterprise Value $26.68m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 8.36
EV/Sales (TTM) EV/Sales 0.26
P/S ratio (TTM) P/S ratio 0.34
P/B ratio (TTM) P/B ratio 1.07
Revenue growth (TTM) Revenue growth 21.38%
Revenue (TTM) Revenue $101.49m
EBIT (operating result TTM) EBIT $609.00k
Free Cash Flow (TTM) Free Cash Flow $3.19m
Cash position $21.60m
EPS (TTM) EPS $-0.03
P/E forward negative
P/S forward 0.52
EV/Sales forward 0.40
Short interest 1.54%
Show more

Is Rockwell Medical, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Rockwell Medical, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Rockwell Medical, Inc. forecast:

3x Buy
100%

Analyst Opinions

3 Analysts have issued a Rockwell Medical, Inc. forecast:

Buy
100%

Financial data from Rockwell Medical, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
101 101
21% 21%
100%
- Direct Costs 84 84
12% 12%
83%
17 17
101% 101%
17%
- Selling and Administrative Expenses 15 15
24% 24%
14%
- Research and Development Expense 0.02 0.02
98% 98%
0%
2.79 2.79
166% 166%
3%
- Depreciation and Amortization 2.18 2.18
11% 11%
2%
EBIT (Operating Income) EBIT 0.61 0.61
109% 109%
1%
Net Profit -0.77 -0.77
91% 91%
-1%

In millions USD.

Don't miss a Thing! We will send you all news about Rockwell Medical, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Rockwell Medical, Inc. Stock News

Neutral
Seeking Alpha
15 days ago
Rockwell Medical, Inc. (NASDAQ:RMTI ) Q4 2024 Earnings Conference Call March 20, 2025 8:00 AM ET Company Participants Heather Hunter - Senior Vice President, Chief Corporate Affairs Officer Mark Strobeck - President & Chief Executive Officer Tim Chole - Chief Commercial Officer Jesse Neri - Chief Financial Officer Conference Call Participants Brandon Folkes - Rodman & Renshaw Ram Selvaraju - H....
Neutral
Business Wire
15 days ago
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical achieves profitability on an adjusted EBITDA basis for the full-year 2024, the first time in the Company's history.
Neutral
Business Wire
24 days ago
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will showcase its hemodialysis concentrates portfolio at DialysisTechConneXion42 on April 1-4, 2025 in Las Vegas, NV in Booth #112.
More Rockwell Medical, Inc. News

Company Profile

Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini in January 1995 and is headquartered in Hackensack, NJ.

Head office United States
CEO Mark Strobeck
Employees 244
Founded 1995
Website www.rockwellmed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today